Exact Sciences
EXAS
#1383
Rank
โ‚ฌ11.80 B
Marketcap
63,92ย โ‚ฌ
Share price
2.34%
Change (1 day)
-9.27%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚ฌ2.88 B

According to Exact Sciences's latest financial reports the company has โ‚ฌ2.88 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚ฌ2.84 B0.29%
2022-12-31$โ‚ฌ2.83 B-4.72%
2021-12-31$โ‚ฌ2.97 B62.82%
2020-12-31$โ‚ฌ1.82 B-10.25%
2019-12-31$โ‚ฌ2.03 B242.81%
2018-12-31$โ‚ฌ0.59 B37.05%
2017-12-31$โ‚ฌ0.43 B36.07%
2016-12-31$โ‚ฌ0.31 B6.47%
2015-12-31$โ‚ฌ0.29 B26.12%
2014-12-31$โ‚ฌ0.23 B142.37%
2013-12-31$โ‚ฌ97.94 M31.3%
2012-12-31$โ‚ฌ74.59 M16.03%
2011-12-31$โ‚ฌ64.29 M6.96%
2010-12-31$โ‚ฌ60.11 M1312.16%
2009-12-31$โ‚ฌ4.25 M-346.84%
2008-12-31$-โ‚ฌ1.73 M-140.43%
2007-12-31$โ‚ฌ4.26 M-62.38%
2006-12-31$โ‚ฌ11.33 M-45.46%
2005-12-31$โ‚ฌ20.78 M-17.27%
2004-12-31$โ‚ฌ25.12 M156.64%
2003-12-31$โ‚ฌ9.78 M-73.32%
2002-12-31$โ‚ฌ36.68 M-45.06%
2001-12-31$โ‚ฌ66.76 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ0.66 B-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.02 B-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.26 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ70.61 B 2,351.21%๐Ÿ‡ซ๐Ÿ‡ท France